Whole cell ELISA for detection of tumor antigen expression in tumor samples

Journal of Immunological Methods

Volumn 258, Issue 1-2, 2001, Pages 47-53

  Erdile, Lorne F ^a,c   Smith, Darlene ^a   Berd, David ^b  

^a AVAX Technologies Inc   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c NONE   (United States)

Author keywords

ELISA; Flow cytometry; Melanoma antigens; Ovarian carcinoma antigens

Indexed keywords

CA 125 ANTIGEN; CANCER VACCINE; GLYCOPROTEIN GP 100; MELANOMA ANTIGEN; PROTEIN S 100; TUMOR ANTIGEN;

ACCURACY; ANTIGEN EXPRESSION; ARTICLE; AUTOMATION; CANCER DIAGNOSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MELANOMA; OVARY CARCINOMA; PATHOLOGY; PRIORITY JOURNAL;

ANTIGENS, NEOPLASM; CA-125 ANTIGEN; CANCER VACCINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGIC TESTS; MELANOMA; MEMBRANE GLYCOPROTEINS; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0035545747     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(01)00465-3     Document Type: Article

References (12)

1. Use of viable-cell ELISA for detection of monoclonal antibodies recognizing tumor-associated antigens on bovine lymphosarcoma cells
2. Reactivity of a monoclonal antibody with human ovarian carcinoma
3. Effusion cytology of malignant melanoma: A morphologic and immunocytochemical analysis including application of the MART-1 antibody
4. Autologous, hapten-modified melanoma vaccine as postsurgical adjuvant treatment after resection of nodal metastases
5. Autologous, hapten-modified vaccine as a treatment for human cancers
6. Heterogeneous expression of immunotherapy candidate proteins gp100, MART-1, and tyrosinase in human melanoma cell lines and in human melanocytic lesions
7. An enzyme-linked immunosorbent assay (ELISA) for the detection of monoclonal antibodies recognizing surface antigens expressed on viable cells
8. The value of tumor marker CA 125 in surgical pathology
9. Immunohistochemical demonstration of S100 protein in malignant melanoma and pigmented nevus, and its diagnostic application
10. Comparison of HMB-45 monoclonal antibody and S-100 protein in the immunohistochemical diagnosis of melanoma
11. Use of an enzyme-linked immunosorbent assay (ELISA) for screening of hybridoma antibodies against cell surface antigens
12. A monoclonal antibody specific for cells of the melanocyte lineage